X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
index medicus (17) 17
male (16) 16
aged (12) 12
middle aged (11) 11
female (9) 9
prostatic neoplasms - drug therapy (8) 8
cancer (7) 7
oncology (7) 7
urology & nephrology (7) 7
adult (6) 6
clinical trials (6) 6
colorectal cancer (6) 6
risk (6) 6
aged, 80 and over (5) 5
evaluation (5) 5
treatment outcome (5) 5
united kingdom (5) 5
aspirin (4) 4
carcinoma (4) 4
care and treatment (4) 4
metastasis (4) 4
prognosis (4) 4
prostate cancer (4) 4
quality of life (4) 4
research (4) 4
survival (4) 4
trial (4) 4
urology (4) 4
analysis (3) 3
androgen-deprivation therapy (3) 3
breast cancer (3) 3
colorectal-cancer (3) 3
disease (3) 3
disease-free survival (3) 3
epidemiology (3) 3
follow-up (3) 3
gonadotropin-releasing hormone - agonists (3) 3
hematology, oncology and palliative medicine (3) 3
hormones (3) 3
medical research (3) 3
medicine, research & experimental (3) 3
men (3) 3
metastatic prostate-cancer (3) 3
mortality (3) 3
parenteral estrogen (3) 3
prevention (3) 3
respiratory system (3) 3
time factors (3) 3
transdermal medication (3) 3
united kingdom - epidemiology (3) 3
abridged index medicus (2) 2
adenoma characteristics (2) 2
administration, cutaneous (2) 2
adolescent (2) 2
androgen antagonists - administration & dosage (2) 2
androgen antagonists - therapeutic use (2) 2
article (2) 2
asthma (2) 2
bias (2) 2
breast neoplasms - diagnosis (2) 2
breast neoplasms - mortality (2) 2
breast-cancer (2) 2
carriers (2) 2
chronic fatigue syndrome (2) 2
clinical-trials (2) 2
colorectal neoplasms - diagnosis (2) 2
colorectal neoplasms - epidemiology (2) 2
colorectal neoplasms - surgery (2) 2
complications and side effects (2) 2
critical care medicine (2) 2
design (2) 2
diagnosis (2) 2
double-blind method (2) 2
drug-related side effects and adverse reactions (2) 2
endoscopy (2) 2
estradiol (2) 2
estradiol - administration & dosage (2) 2
estrogen (2) 2
estrogens - administration & dosage (2) 2
follow-up studies (2) 2
fractures, bone - chemically induced (2) 2
impact (2) 2
incidence (2) 2
kaplan-meier estimate (2) 2
mass screening (2) 2
medicine (2) 2
metaanalysis (2) 2
methods (2) 2
models, statistical (2) 2
neoplasm recurrence, local - epidemiology (2) 2
outcomes (2) 2
overdiagnosis (2) 2
patient outcomes (2) 2
pharmacology (2) 2
pharmacology & pharmacy (2) 2
predictors (2) 2
program (2) 2
prospective studies (2) 2
prostatic neoplasms - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 49 - 57
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 4, pp. 306 - 316
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2009, Volume 116, Issue 1, pp. 179 - 185
BACKGROUND: Evidence of the impact of breast screening is limited by biases inherent in non-randomised studies and often by lack of complete population data.... 
Length bias | Population screening | Mammography | Lead-time bias | Self-selection bias | MORTALITY | TRIAL | IMPACT | ONCOLOGY | FOLLOW-UP | OVERDIAGNOSIS | PROGRAM | Bias | Humans | Middle Aged | Kaplan-Meier Estimate | Risk | Time | Mass Screening | Survival Analysis | Breast Neoplasms - mortality | Female | Aged | Breast Neoplasms - diagnosis | Research Design | Cohort Studies
Journal Article
Contemporary Clinical Trials, ISSN 1551-7144, 2016, Volume 51, pp. 56 - 64
Abstract Background There is a considerable body of pre-clinical, epidemiological and randomised data to support the hypothesis that aspirin has the potential... 
Hematology, Oncology and Palliative Medicine | Cardiovascular | Aspirin | Gastro-oesophageal cancer | Breast cancer | Prostate cancer | Colorectal cancer | Randomised controlled trial | ADJUVANT CHEMOTHERAPY | MORTALITY | MEDICINE, RESEARCH & EXPERIMENTAL | ANTIINFLAMMATORY DRUG-USE | FOLLOW-UP | RISK | BREAST-CANCER | COLON-CANCER | COLORECTAL-CANCER | PROSTATE-CANCER | RUN-IN | PHARMACOLOGY & PHARMACY | Humans | Male | Tinnitus - chemically induced | Colorectal Neoplasms - drug therapy | Prostatic Neoplasms - blood | Female | Aspirin - therapeutic use | Chemotherapy, Adjuvant | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Drug Hypersensitivity - etiology | Double-Blind Method | India - epidemiology | Survival Rate | Stomach Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Disease-Free Survival | Gastrointestinal Hemorrhage - chemically induced | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Intracranial Hemorrhages - chemically induced | Neoplasm Recurrence, Local - epidemiology | Macular Degeneration - chemically induced | Peptic Ulcer - chemically induced | Esophageal Neoplasms - drug therapy | Longitudinal Studies | United Kingdom - epidemiology | Medical research | Relapse | Analysis | Clinical trials | Medicine, Experimental | Metastasis | Epidemiology | Diseases | Index Medicus
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 11/2005, Volume 19, Issue 6, p. 647
  Fourteen patients (7 male, 7 female, 22-63 years), classified as having chronic fatigue syndrome (CFS), but without concurrent major depression, significant... 
Sleep | Cognition & reasoning | Pharmacology | Drug therapy | Chronic fatigue syndrome
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 67, Issue 3, pp. 534 - 543
Journal Article
Clinical trials (London, England), ISSN 1740-7745, 10/2017, Volume 14, Issue 5, pp. 451 - 461
There is real need to change how we do some of our clinical trials, as currently the testing and development process is too slow, too costly and too... 
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2011, Volume 185, Issue 6, pp. 2430 - 2432
Journal Article
JAMA Oncology, ISSN 2374-2437, 08/2019, Volume 5, Issue 8, pp. 1181 - 1187
ImportancePerioperative chemotherapy and surgery are a standard of care for operable gastroesophageal adenocarcinoma. Anti-HER2 therapy improves survival in... 
HER2 | ESOPHAGEAL | GASTRIC-CANCER | ONCOLOGY | Online First | Original Investigation | Research
Journal Article